Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 157

1.

Long non-coding RNA expression profiles predict clinical phenotypes in glioma.

Zhang X, Sun S, Pu JK, Tsang AC, Lee D, Man VO, Lui WM, Wong ST, Leung GK.

Neurobiol Dis. 2012 Oct;48(1):1-8. doi: 10.1016/j.nbd.2012.06.004. Epub 2012 Jun 16.

PMID:
22709987
[PubMed - indexed for MEDLINE]
2.

Coexpression network analysis identifies transcriptional modules related to proastrocytic differentiation and sprouty signaling in glioma.

Ivliev AE, 't Hoen PA, Sergeeva MG.

Cancer Res. 2010 Dec 15;70(24):10060-70. doi: 10.1158/0008-5472.CAN-10-2465.

PMID:
21159630
[PubMed - indexed for MEDLINE]
Free Article
3.

Aberrant expression of long noncoding RNAs in cervical intraepithelial neoplasia.

Gibb EA, Becker-Santos DD, Enfield KS, Guillaud M, Niekerk Dv, Matisic JP, Macaulay CE, Lam WL.

Int J Gynecol Cancer. 2012 Nov;22(9):1557-63. doi: 10.1097/IGC.0b013e318272f2c9.

PMID:
23095774
[PubMed - indexed for MEDLINE]
4.

Analysis of lncRNA expression profiles in non-small cell lung cancers (NSCLC) and their clinical subtypes.

Yang J, Lin J, Liu T, Chen T, Pan S, Huang W, Li S.

Lung Cancer. 2014 May 22. pii: S0169-5002(14)00220-7. doi: 10.1016/j.lungcan.2014.05.011. [Epub ahead of print] Review.

PMID:
24906504
[PubMed - as supplied by publisher]
5.

Expression of multiple larger-sized transcripts for several genes in oligodendrogliomas: potential markers for glioma subtype.

Xu X, Joh HD, Pin S, Schiller NI, Prange C, Burger PC, Schiller MR.

Cancer Lett. 2001 Sep 28;171(1):67-77.

PMID:
11485829
[PubMed - indexed for MEDLINE]
6.
7.

LncRNA profile of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis.

Han L, Zhang K, Shi Z, Zhang J, Zhu J, Zhu S, Zhang A, Jia Z, Wang G, Yu S, Pu P, Dong L, Kang C.

Int J Oncol. 2012 Jun;40(6):2004-12. doi: 10.3892/ijo.2012.1413. Epub 2012 Mar 23.

PMID:
22446686
[PubMed - indexed for MEDLINE]
8.
9.

BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas.

Idbaih A, Marie Y, Lucchesi C, Pierron G, Manié E, Raynal V, Mosseri V, Hoang-Xuan K, Kujas M, Brito I, Mokhtari K, Sanson M, Barillot E, Aurias A, Delattre JY, Delattre O.

Int J Cancer. 2008 Apr 15;122(8):1778-86.

PMID:
18076069
[PubMed - indexed for MEDLINE]
10.

[CDK1 expression and effects of CDK1 silencing on the malignant phenotype of glioma cells].

Chen H, Huang Q, Zhai DZ, Dong J, Wang AD, Lan Q.

Zhonghua Zhong Liu Za Zhi. 2007 Jul;29(7):484-8. Chinese.

PMID:
18069625
[PubMed - indexed for MEDLINE]
11.

Prediction of novel long non-coding RNAs based on RNA-Seq data of mouse Klf1 knockout study.

Sun L, Zhang Z, Bailey TL, Perkins AC, Tallack MR, Xu Z, Liu H.

BMC Bioinformatics. 2012 Dec 13;13:331. doi: 10.1186/1471-2105-13-331.

PMID:
23237380
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

A long non-coding RNA signature in glioblastoma multiforme predicts survival.

Zhang XQ, Sun S, Lam KF, Kiang KM, Pu JK, Ho AS, Lui WM, Fung CF, Wong TS, Leung GK.

Neurobiol Dis. 2013 Oct;58:123-31. doi: 10.1016/j.nbd.2013.05.011. Epub 2013 May 29.

PMID:
23726844
[PubMed - indexed for MEDLINE]
13.

Molecular pathways in the formation of gliomas.

von Deimling A, Louis DN, Wiestler OD.

Glia. 1995 Nov;15(3):328-38. Review.

PMID:
8586467
[PubMed - indexed for MEDLINE]
14.

Pleiotrophin expression in astrocytic and oligodendroglial tumors and it's correlation with histological diagnosis, microvascular density, cellular proliferation and overall survival.

Peria FM, Neder L, Marie SK, Rosemberg S, Oba-Shinjo SM, Colli BO, Gabbai AA, Malheiros SM, Zago MA, Panepucci RA, Moreira-Filho CA, Okamoto OK, Carlotti CG Jr.

J Neurooncol. 2007 Sep;84(3):255-61. Epub 2007 Apr 19.

PMID:
17443289
[PubMed - indexed for MEDLINE]
15.

Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes.

Godard S, Getz G, Delorenzi M, Farmer P, Kobayashi H, Desbaillets I, Nozaki M, Diserens AC, Hamou MF, Dietrich PY, Regli L, Janzer RC, Bucher P, Stupp R, de Tribolet N, Domany E, Hegi ME.

Cancer Res. 2003 Oct 15;63(20):6613-25.

PMID:
14583454
[PubMed - indexed for MEDLINE]
Free Article
16.

Molecular genetic evidence for subtypes of oligoastrocytomas.

Maintz D, Fiedler K, Koopmann J, Rollbrocker B, Nechev S, Lenartz D, Stangl AP, Louis DN, Schramm J, Wiestler OD, von Deimling A.

J Neuropathol Exp Neurol. 1997 Oct;56(10):1098-104.

PMID:
9329453
[PubMed - indexed for MEDLINE]
17.

Gene expression analyses of grade II gliomas and identification of rPTPbeta/zeta as a candidate oligodendroglioma marker.

Hägerstrand D, Smits A, Eriksson A, Sigurdardottir S, Olofsson T, Hartman M, Nistér M, Kalimo H, Ostman A.

Neuro Oncol. 2008 Feb;10(1):2-9. Epub 2007 Nov 14.

PMID:
18003890
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Gene expression profiling identifies molecular subtypes of gliomas.

Shai R, Shi T, Kremen TJ, Horvath S, Liau LM, Cloughesy TF, Mischel PS, Nelson SF.

Oncogene. 2003 Jul 31;22(31):4918-23. Erratum in: Oncogene. 2006 Jul 13;25(30):4256.

PMID:
12894235
[PubMed - indexed for MEDLINE]
19.

Long non-coding RNAs in glioma: Functional roles and clinical perspectives.

Zhang XQ, Leung GK.

Neurochem Int. 2014 Jun 2. pii: S0197-0186(14)00130-2. doi: 10.1016/j.neuint.2014.05.008. [Epub ahead of print] Review.

PMID:
24887176
[PubMed - as supplied by publisher]
20.

[Analysis of S100beta-v-erbB transgenic rats prone to brain tumors].

Yokoo H, Tanaka Y, Nobusawa S, Nakazato Y, Ohgaki H.

Brain Nerve. 2009 Jul;61(7):765-72. Review. Japanese.

PMID:
19618853
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk